<DOC>
<DOCNO>
EP-0008802
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
C07D-457/00 <main>C07D-457/02</main> A61P-9/00 A61P-9/12 C07D-457/02 A61K-31/48 C07D-457/04 
</IPC-CLASSIFICATIONS>
<TITLE>
ergoline derivatives, their preparation and therapeutic composition containing them.
</TITLE>
<APPLICANT>
erba farmitaliait<sep>farmitalia±carlo±erba s.p.a.<sep>farmitalia carlo erba s.p.a.via carlo imbonati, 24i-20159 milanoit<sep>farmitalia carlo erba s.p.a.<sep>
</APPLICANT>
<INVENTOR>
arcari giuliana dr biolog<sep>bosisio germano via de santis<sep>caravaggi anna maria<sep>mantegani sergio<sep>arcari, giuliana, dr. biolog.<sep>bosisio, germano via de santis, 23/b<sep>caravaggi, anna maria<sep>mantegani, sergio<sep>arcari, giuliana, dr. biolog.via sismondi 4i-milanit<sep>bosisio, germano via de santis, 23/bpalazzolo milanese (paderno dugnano)i-milanit<sep>caravaggi, anna mariavia conca del naviglio 22i-milanit<sep>mantegani, sergiovia carlo pisacane 57i-milanit<sep>arcari, giuliana, dr. biolog.<sep>bosisio, germano via de santis, 23/b<sep>caravaggi, anna maria <sep>mantegani, sergio<sep>arcari, giuliana, dr. biolog. via sismondi 4 i-milan it<sep>bosisio, germano via de santis, 23/bpalazzolo milanese (paderno dugnano)i-milanit<sep>caravaggi, anna mariavia conca del naviglio 22i-milanit<sep>mantegani, sergiovia carlo pisacane 57i-milanit<sep>
</INVENTOR>
<ABSTRACT>
the novel ergoline derivatives of the general formula i    wherein r₁ represents an ally or alkoxy group having from 1  to 4 carbon atoms, phenyl, a 5- or 6-membered heterocyclic  ring which is preferably saturated, an amino group, a substi­ tuted amino group of the formula nhr′ (wherein r′ repres­ ents an alkyl group having from 1 to 4 carbona toms, a cyc­ loalkyl group, a benzyl group or a phenyl group), or a substi­ tuted amino group of the formula nr″r‴ (wherein r″ and  r‴ both represent alkyl groups having from 1 to 4 carbon  atoms);   r₂ represents a hydrogen atom, an alkyl group having from 1  to 4 carbon atoms or a phenyl group;   r₃ represents a halogen atom, a cyano group, a halogenated  lower alkyl group, methylthio, methylsulfonyl or sulfonamido  group, an alkoxy group having from 1 to 4 carbon atoms, an  acyl group, having from 2 to 5 carbon atoms or a benzoyl  group;   r₄ represents a hydrocarbon group having from 1 to 4 carbon  atoms;   r⁵ represents a hydrogen atom or a methoxy group;   r₆ is hydrogen, a halogen atom or a methyl group;   r₇ is hydrogen or a methyl group;   and the pharmaceutically acceptable addition salts with  organic or inorganic acids thereof exhibit antihypertensive  and antiprolactinic activity.  their preparation is described,  e. g.  2-cyano3- (6′-methyl-ergoline-8′β)-propionic acid ethyl  ester is obtained by reacting sodium ethyl cyanoacetate with  6-methyl-8β-tosyloxymethylergoline.  
</ABSTRACT>
</TEXT>
</DOC>
